Tokinolide B is a natural compound primarily studied for its anti-inflammatory, neuroprotective, and potential anti-cancer properties. It has shown activity in modulating pathways associated with oxidative stress and neuronal damage, making it a compound of interest in the development of treatments for neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Research also indicates that it may inhibit certain pro-inflammatory cytokines and enzymes, suggesting possible applications in managing chronic inflammatory diseases. Additionally, it exhibits potential in inhibiting the growth of certain cancer cells at the cellular level. Its ability to cross the blood-brain barrier enhances its suitability for central nervous system-targeted therapies. While still in the preclinical research phase, Tokinolide B represents a promising candidate for future pharmaceutical development in neurology, immunology, and oncology.